Ledger.Open graph →

SEC Form D · Amendment · filed August 8, 2024

Noveome Biotherapeutics, Inc

Offering

$51.3M

Sold

$36.2M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

PITTSBURGH, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Patrick Welch · Pittsburgh, PAExec Ronald Poropatich · Pittsburgh, PADirector Michael Kaufman · Pittsburgh, PADirector Eric Keller · Pittsburgh, PADirector Gretchen Kraemer · Pittsburgh, PAExec Houman Hemmati · Pittsburgh, PADirector Robert Langer · Pittsburgh, PADirector Craig Nemiroff · Pittsburgh, PADirector Houman Hemmati · Pittsburgh, PADirector Ronald Poropatich · Pittsburgh, PADirector Craig Nemiroff · Pittsburgh, PADirector Andrew J. Spokes · San Francisco, CAExec Eric Keller · Pittsburgh, PADirector Michael Kaufman · Pittsburgh, PADirector Steven Shores · Atlanta, GADirector Gretchen Kraemer · Pittsburgh, PAExec Michael Huber · New York, NYDirector Bradley Fishman · New York, NYExec Daniel P. Gould · Pacifica, CADirector Douglas Root · Arlington, VADirector Andrew W. Buchanan · Arlington, VADirector Blackfin Real Estate Investors, LLC · Arlington, VADirector Matt Wan · San Francisco, CAExec William Hicks · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗